Quantum dot-doped silica nanoparticles as probes for targeting of T-lymphocytes by Bottini, Massimo et al.
International Journal of Nanomedicine 2007: 2(2) 227–233
© 2007 Dove Medical Press Limited.  All rights reserved
227
ORIGINAL RESEARCH
Quantum dot-doped silica nanoparticles as 
probes for targeting of T-lymphocytes
Massimo Bottini1,2,4
Federica D’Annibale2
Andrea Magrini2
Fabio Cerignoli1
Yutaka Arimura1
Marcia I Dawson1
Enrico Bergamaschi5
Nicola Rosato3
Antonio Bergamaschi1
Tomas Mustelin1
1Burnham Institute for Medical 
Research, La Jolla, CA, USA; 2NAST 
and Department of Environmental, 
Occupational and Social Medicine, 
University of Rome Tor Vergata, 
Rome, Italy; 3NAST and Department 
of Experimental Medicine and 
Biochemical Sciences, University of 
Rome Tor Vergata, Rome, Italy; 4INFN, 
Laboratori Nazionali di Frascati, 
Frascati, Italy; 5Department of Clinical 
Medicine, Nephrology and Health 
Sciences, University of Parma, Parma, 
Italy 
Correspondence: Massimo Bottini
Burnham Institute for Medical Research, 
10901 North Torrey Pines Road, La Jolla, 
CA 92037, USA
Tel +1 858 646 3100 x3063
Email mbottini@burnham.org
Abstract: To enhance diagnostic or therapeutic efficacy, novel nanomaterials must 
be engineered to function in biologically relevant environments, be visible by conventional 
ﬂ  uorescent microscopy, and have multivalent loading capacity for easy detection or effective 
drug delivery. Here we report the fabrication of silica nanoparticles doped with quantum dots 
and superﬁ  cially functionalized with amino and phosphonate groups. The amino groups were 
acylated with a water-soluble biotin-labeling reagent. The biotinylated nanoparticles were 
subsequently decorated with neutravidin by exploiting the strong afﬁ  nity between neutravidin 
and biotin. The resultant neutravidin-decorated ﬂ  uorescent silica nanoparticles stably dispersed 
under physiological conditions, were visible by conventional optical and confocal ﬂ  uorescent 
microscopy, and could be further functionalized with macromolecules, nucleic acids, and 
polymers. We also coated the surface of the nanoparticles with biotinylated mouse anti-human 
CD3 (αCD3). The resultant ﬂ  uorescent nanoassembly was taken up by Jurkat T cells through 
receptor-mediated endocytosis and was partially released to lysosomes. Thus, quantum dot-
doped silica nanoparticles decorated with neutravidin represent a potentially excellent scaffold 
for constructing speciﬁ  c intracellular nanoprobes and transporters. 
Keywords: silica nanoparticles, neutravidin, surface functionalization, endocytosis, intracel-
lular nanoprobe
Introduction
The emerging ﬁ  eld of nanomedicine is aimed at the preservation and improvement 
of human health using the tools and knowledge of nanotechnology and may lead to 
the development of more effective means for diagnosing and treating malignancies as 
compared with current methods. To enhance diagnostic or therapeutic efﬁ  cacy, novel 
nanoassemblies must be engineered to function in biologically relevant environments 
and have multivalent loading capacity to facilitate detection or effective drug delivery. 
In the past decade, several types of nanoparticles have been prepared and evaluated 
for tissue targeting, sensing and imaging, and localized therapy (Akerman et al 2002; 
Salem et al 2003; Bianco 2004; Haag 2004; Langer and Tirrell 2004; Bottini et al 
2006a; Shenoy et al 2006). Often, the chemistry of these nanoparticles has limited 
their stepwise assembly into multilayered systems and their capacity to interact mul-
tivalently with cell membrane receptors.
Silica nanoparticles (SNP) have been widely used for biosensing and catalytic ap-
plications due to their large surface area to volume ratio, easy fabrication and capacity 
for doping and/or functionalization with ﬂ  uorescent molecules (Bottini et al 2006b), 
magnetic nanoparticles (Wang et al 2005), or semiconducting nanocrystals (Lin 
et al 2006). SNP can be prepared using several methods, including the popular Stobër 
(Stobër et al 1968) and the water-in-oil nanoemulsion (Bagwe et al 2004) techniques. 
The former employs simple hydrolysis of a silica precursor in ethanolic-ammonium hy-
droxide medium while the latter uses water droplets in reverse micelles as nanoreactors International Journal of Nanomedicine 2007:2(2) 228
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to regulate nanosphere size which is dependent on water 
droplet dimension, ie, molar ratios of water to surfactant and 
the precursor, molar ratio of precursor to catalyst, precursor 
reactivity, and reaction time and temperature. 
Quantum dots (QD) are colloidal semiconducting nano-
crystals that have diameters of a few nanometers and are 
typically coated with functionalized polymers that permit 
the surface tethering of various small and macro-molecules 
that are compatible with an aqueous environment. Because 
of their small size, QD energy levels are quantized so that 
photon energy emission is restricted to a narrow range after 
broad range absorption. Their quantum behavior is superior 
to that of small organic ﬂ  uorescent molecules, which can 
only ﬂ  uoresce after excitation within a narrow absorption 
range and bleach rapidly. Therefore, QD represent an excel-
lent building block for intracellular nanoprobes and delivery 
systems. However, QD have caused in vitro toxic effects 
that depend on such factors as dose, size, and chemical 
functionalization (Hardman 2006). Their solubilization under 
physiological conditions and superﬁ  cial functionalization are 
not straightforward. However encapsulation of QD by SNP 
has been found to increase their hydrophilicity and decrease 
their cytotoxicity (Zhang et al 2006). In this regard, SNP 
encapsulation offers the advantage that speciﬁ  c functional 
groups can be easily introduced on their surface to reduce 
aggregation and permit further functionalization to obtain 
nanoassemblies (Bagwe et al 2006). 
In this report we describe the construction and character-
ization of SNP doped with QD and decorated with neutravidin 
(Nav). To demonstrate that this ﬂ  uorescent nanoassembly 
could be further functionalized with small or macro-
molecules, we coated its surface with biotinylated mouse 
anti-human CD3 (αCD3) by exploiting the strong afﬁ  nity 
between biotin and Nav. We next investigated the uptake of 
the resultant QD-SNP-Nav-αCD3 nanoassembly into human 
Jurkat T cells through receptor-mediated endocytosis. Thus, 
this nanoassembly represents a potentially excellent scaffold 
for constructing speciﬁ  c intracellular nanoprobes.
Materials and methods
Materials
Unless otherwise noted, reagent-grade chemicals were used 
without further puriﬁ  cation, and Millipore water was used for 
all aqueous solutions. Cyclohexane, Triton X-100, n-hexanol, 
tetramethyl orthosilicate (tmos), (3-aminopropyl)trimetho
xysilane (apts), (3-trihydroxy)silylpropyl methylphospho-
nate (thpmp), ammonium hydroxide (28% NH3 in water), 
poly-L-lysine, formaldehyde, dimethyl formamide (DMF), 
and phosphate-buffered saline (PBS) were purchased from 
Sigma-Aldrich (St. Louis, MO). ZnS-covered CdSe QD were 
capped by (trioctyl)phosphine oxide (TOPO) had a 542-nm 
emission wavelength and a diameter of approximately 2 nm 
and were obtained from Evident Technologies, Inc. (Troy, 
NY). The water-soluble biotin-labeling reagent sulfosuc-
cinimidyl-6-(biotin-amido)hexanoate (sulfo-NHS-LC-biotin) 
and neutravidin (Nav, molecular weight approximately 
6 × 104) were purchased from Pierce Biotechnology, Inc. 
(Rockford, IL). Biotinylated and nonconjugated αCD3 an-
tibodies (molecular weight approximately 1.5 × 105) were 
from eBioscience, Inc. (San Diego, CA); rabbit anti-human 
CD107A (LAMP-1) antibody was a gift from Prof. Minoru 
Fukuda (Burnham Institute for Medical Research, La Jolla, 
CA). Texas Red-labeled goat anti-rabbit antibody and Texas 
Red-labeled concanavalin A were from Molecular Probes 
(Invitrogen Corp., Carlsbad, CA); normal mouse serum 
(NMS) was from Santa Cruz Biotechnology (Santa Cruz, 
CA); normal goat serum (NGS) was from Gibco (Invitrogen 
Corp., Carlsbad, CA); fetal bovine serum (FBS) was from 
Tissue Culture Biologicals (Informagen, Inc., Newington, 
NH); RPMI-1640 cell culture medium and Dulbecco’s modi-
ﬁ  ed Eagle’s medium-high glucose (DMEM-HG) were from 
Cellgro (Mediatech, Inc., Herndon, VA). 
Preparation of QD-SNP-Nav
Unless otherwise stated all incubations were done at room 
temperature. A mixture of cyclohexane, Triton X-100, and 
n-hexanol (volume ratio 4.2:1:1; 24.8-ml ﬁ  nal volume) was 
converted to a nanoemulsion by stirring at room temperature 
for 1 h before water (940 μl) and tmos (100.5 μl) were added. 
This mixture was sonicated for 1 h to facilitate the diffusion 
of tmos into the encapsulated water droplets. A drop (59 μl) 
of 28% aqueous ammonium hydroxide was added to catalyze 
the hydrolysis and condensation of tmos and the mixture 
was stirred for 30 min. Next, 25 nmoles of QD in toluene 
(100 μl) were added. The reaction mixture was stirred for 
24 h before tmos (10 μl) was added, followed by a mixture of 
apts (5.9 μl) and thpmp (15.1 μl) 30 min later. This mixture 
was stirred for 24 h. The QD-doped SNP (QD-SNP, Scheme 
1[I]) were precipitated by acetone (25 ml). The precipitate 
(approximately 25 mg of nanoparticles) was washed several 
times with water, followed by anhydrous ethanol. A 1 mg 
aliquot of QD-SNP and 30 mg of sulfo-NHS-LC-biotin were 
stirred for 2 hours in phosphate buffered saline (PBS, 2 ml). 
The biotinylated nanoparticles (QD-SNP-bio, Scheme 1[II]) 
were washed three times with PBS and then incubated with International Journal of Nanomedicine 2007:2(2) 229
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5 mg of Nav overnight. The QD-SNP-Nav (Scheme 1[III]) 
were washed with PBS until the absorbance of the wash at 
280 nm demonstrated the absence of protein. 
Internalization of QD-SNP-Nav by 
CD3-mediated endocytosis
QD-SNP-Nav (100 μg) were incubated with biotinylated 
αCD3 antibody (20 μg) for 1 h (Scheme 1[IV]). The QD-
SNP-Nav-αCD3 were washed three times with PBS. Human 
Jurkat T leukemia cells were grown at 37 °C in 5% CO2 in 
RPMI-1640 supplemented with 10% FBS. Cells (105) in 
logarithmic growth were washed with RPMI-1640, resus-
pended in 0.5 ml of RPMI-1640, incubated with QD-SNP-
Nav-αCD3 (7 μg) in PBS (300 μl) for 3 h at 37 °C in 5% 
CO2, washed twice in PBS and then incubated for 30 min at 
37 °C in 5% CO2 on poly-L-lysine-coated cover slips. HeLa 
adenocarcinoma cells were seeded onto cover slips, main-
tained in logarithmic growth by culture in DMEM-HG for 24 
h and then treated with QD-SNP-Nav-αCD3 in PBS for 3 h 
at 37 °C in 5% CO2. The cells on the cover slips were ﬁ  xed 
for 10 min in 3.7% formaldehyde in PBS, blocked and per-
meabilized with PBS containing 5% NMS and 0.3% Triton 
X-100, and then either stained for 1 h at room temperature 
with 10 μg/ml Texas Red-conjugated concanavalin A, or 
incubated with rabbit anti-CD107A in PBS containing 3% 
NMS and 0.1% Triton X-100 followed by staining with Texas 
Red-labeled goat anti-rabbit antibody in PBS containing 3% 
NGS and 0.1% Triton X-100. The nucleus was visualized 
using mounting medium containing DAPI (VECTASHIELD, 
Vector Laboratories, Inc., Burlingame, CA).
Fluorescent microscopy
Phase-contrast and ﬂ  uorescence images of functionalized 
SNP were acquired using an inverted microscope (TE300 
Nikon, Kanagawa, Japan). Fluorescent imaging was per-
formed using a confocal microscope (Radiance 2100/AGR-
3Q, Bio Rad, Hercules, CA) after excitation either at 488 nm 
using an argon laser to excite the QD, or at 568 nm using 
a krypton laser to excite the Texas Red. Both 40× and 60× 
(1.4-oil immersion) objectives were used. Wet samples were 
imaged to avoid any ﬂ  uorescence interference from salt 
crystals caused by evaporation of buffer.
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Scheme 1 Quantum dot (QD)-doped silica nanoparticles (SNP) functionalized with amino and phosphonate groups (I), after coupling of the QD-SNP amino groups to a 
biotin-labeling reagent (II), decoration of QD-SNP-bio with neutravidin (Nav) (III), and after incubation of QD-SNP-Nav with biotinylated mouse anti-human CD3 (IV).International Journal of Nanomedicine 2007:2(2) 230
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Transmission electron microscopy
An aliquot (3 μl) of QD-SNP in ethanol was dropped onto 
lacey carbon ﬁ  lm covering a 300-mesh copper grid (Tedpella, 
Inc., Redding, CA) allowing the ethanol to evaporate. Trans-
mission electron microscopy (TEM) images were obtained 
using a Hitachi H-600A (Tokyo, Japan).
Results and discussion
Molecular weight estimation of QD-SNP
TEM images of the QD-SNP showed a uniform diameter 
(20 ± 1 nm) of silica nanoparticles functionalized with 
3-aminopropyl and phosphonopropyl groups. Assuming that 
the density of the SNP was equal to pure silica (1.96 g/cm3) 
and that the weight of encapsulated QD was negligible, the 
weight of one SNP having a 20-nm diameter was calculated 
(1.96 × 4/3πr3) to be approximately 8.2 × 10-18g. Therefore, the 
molecular weight of a QD-SNP was calculated (weight × 
Avogadro number) as approximately 5 × 106. 
Loading of Nav on QD-SNP-Nav
The phosponate groups on the QD-SNP surface facilitated 
the dispersion of nanoparticles in PBS and the subsequent 
coupling of the SNP amino groups to the biotin-labeling 
reagent followed by the decoration of SNP-bio with Nav. 
The presence of linked Nav on the surface of QD-SNP was 
initially determined on the basis of the following observa-
tion. It has been reported that biotin binding blue-shifts the 
tryptophan ﬂ  uorescence emission peak (λmax) and reduces the 
bandwidth at half height (full-width half-maximum, FWHM) 
(Kurzban et al 1990). Streptavidin and Nav are tetrameric 
proteins carrying three tryptophans in each monomer. Upon 
excitation at 290 nm QD-SNP-Nav dispersion in PBS showed 
an emission band that was blue-shifted and narrower than 
that exhibited by free Nav dispersed in PBS (Figure 1 and 
Table 1). We prepared mixtures having molar ratios between 
Nav and biotin from 1:1 to 1:4. After 2 hours of incubation, 
we collected their emission spectra after excitation at 290 nm. 
The tryptophan ﬂ  uorescence emission peak was observed to 
blue-shift and narrow with increasing biotin. Speciﬁ  cally in 
the case of a Nav:biotin molar ratio equal to 1:2, the emis-
sion spectrum resembled that exhibited by QD-SNP-Nav 
suggesting that each Nav was linked to QD-SNP-bio through 
approximately 2 biotin molecules. 
We recorded the absorbance value at 283 nm of Nav in 
PBS for several concentrations of the protein and calculated 
an extinction coefﬁ  cient of Nav in PBS at 283 nm (εNav) 
equal to approximately 1.1 × 105 M-1cm-1. We subtracted the 
absorbance spectrum of QD-SNB in PBS from the spectrum 
of QD-SNB-Nav to obtain the spectrum of Nav linked to QD-
SNP. From the value of absorbance at 283 nm of Nav linked 
to QD-SNP and the previously calculated εNav we calculated 
that approximately 40 proteins were on each SNP. 
Spectroscopic characterization of 
QD-SNP-Nav
For up to several months QD-SNP-Nav in PBS at 4 °C 
remained as a clear solution without any visible ﬂ  occula-
tion. Moreover, the QD-SNP-Nav in PBS exhibited intense 
ﬂ  uorescence (Figure 2). These results, which suggest that 
the QD-SNP-Nav was a monodispersed suspension, were 
conﬁ  rmed by both optical and confocal microscopy which 
showed that QD-SNP-Nav in PBS had no distinct ﬂ  uorescent 
features (Figure 3). The absorbance spectrum of QD-SNP-
Nav in PBS exhibited a blue-shifted band that was broader 
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Figure 1 Normalized emission spectra on excitation upon 290 nm for QD-SNP-Nav dispersed in PBS and for mixtures with different molar ratios of Nav and biotin in PBS. 
Abbreviations: Nav, neutravidin; PBS, phosphate-buffered saline; QD, quantum dots; SNP, silica nanoparticles.International Journal of Nanomedicine 2007:2(2) 231
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than the corresponding 531 nm-centered band of QD sus-
pended in toluene (Figure 4A). After excitation at 488 nm, 
the steady-state emission spectrum of QD-SNP-Nav in PBS 
exhibited a slightly broader and blue-shifted emission peak 
compared to that of free QD in toluene (Figure 4B and 
Table 2). QD are characterized by spectroscopic properties 
strictly dependent upon their physical dimension. In particu-
lar, the maximum in the absorption spectrum (corresponding 
to the ﬁ  rst electronic transition) and the emission peak shift to 
shorter wavelengths with decreasing size of the nanocrystal. 
Therefore, the blue-shift of both absorption and emission 
bands could be explained by considering a decrease of the 
size of the nanocrystal core due to a partial oxidation of 
the QD surface during the hydrolysis and condensation of the 
silica precursor. The broadening of the maximum of the ﬁ  rst 
electronic transition in the absorption spectrum may be due to 
a change of the refractive index of the medium surrounding 
the QD after the encapsulation into the silica matrix.
Internalization of QD-SNP-Nav by 
CD3-mediated endocytosis
The transport of various types of proteins that were noncova-
lently and nonspeciﬁ  cally bound to engineered nanomateri-
als into various adherent and nonadherent mammalian cell 
lines by endocytosis has been reported (Kam and Dai 2005). 
Recently, our group reported the internalization of a carbon 
nanotube-based supramolecular luminescent nanoassembly 
by Jurkat cells that had been stimulated with biotinylated 
αCD3 (Bottini et al 2006a). The decoration of QD-SNP 
with neutravidin stably solubilized the QD-SNP-Nav under 
physiological conditions and, therefore, provided a potential 
scaffold for intracellular transporters. Here, we investigated 
whether QD-SNP-Nav could be used as a ﬂ  uorescently 
detectable intracellular nanoprobe in Jurkat cells through 
speciﬁ  c CD3 receptor-mediated endocytosis. 
QD-SNP-Nav (100 μg, 2 × 10-11 mol of SNP assuming 
a molecular weight of 5 × 106) were ﬁ  rst incubated with 
biotinylated αCD3 (20 μg, 1.33 × 10-10 mol of antibodies 
assuming a molecular weight of 1.5 × 105) to introduce 
αCD3 by binding of its biotin moiety to unoccupied sites 
on Nav (QD-SNP-Nav-αCD3) and then washed three times 
with PBS. In this way, we avoided preliminary treatment of 
cells with antibodies, and were able to obtain improved CD3 
binding as compared to the previously published intracellular 
nanoprobes. We veriﬁ  ed the amount of αCD3 linked to the 
QD-SNP-Nav using polyacrylamide gel electrophoresis and 
Western immuno-blotting. The fact that the supernatant frac-
tion collected after the ﬁ  rst wash did not contain free antibod-
ies suggested that all the antibodies were linked to the Nav 
on the QD-SNP and, therefore, that approximately 6 αCD3 
antibodies were available for each QD-SNP-Nav-αCD3. 
Endocytosis is an energy-dependent process with opti-
mum uptake occurring at 37 °C but none occurring at 4 °C. 
Jurkat cells that were incubated with QD-SNP-Nav-αCD3 
at 37 °C had intense internal ﬂ  uorescence (Figure 5A). 
To investigate whether internalized QD-SNP-Nav-αCD3 
localized in the nucleus, the cells were stained with the 
Table 1 Maximum emission wavelength and full-width half-
maximum for QD-SNP-Nav dispersed in PBS and for mixtures 
with different molar ratios of Nav and biotin in PBS, after 
excitation at 290 nm
Sample  λmax
† (nm)  FWHM‡ (nm)
QD-SNP-Nav 338  60
Nav:biotin = 1:0  346  63
Nav:biotin = 1:1  341  61
Nav:biotin = 1:2  337  59
Nav:biotin = 1:3  333  56
Nav:biotin = 1:4  332  55
Notes: †maximum emission wavelength; ‡full-width half-maximum.
Abbreviations: Nav, neutravidin; PBS, phosphate-buffered saline; QD, quantum 
dots; SNP, silica nanoparticles. 
Figure 2 Photographs of QD-SNP-Nav in PBS before (left) and after (right) illumi-
nation with 365-nm UV light.
Abbreviations: Nav, neutravidin; PBS, phosphate-buffered saline; QD, quantum 
dots; SNP, silica nanoparticles; UV, ultraviolet.
Table 2 Maximum emission wavelength and full-width half-
maximum for dipersions of QD in toluene and QD-SNP-Nav 
in PBS, after excitation at 488 nm
Sample  λmax
† (nm)  FWHM‡ (nm)
QD in toluene 542  28
QD-SNP-Nav in PBS 538  32
Note: †maximum emission wavelength; ‡full-width half-maximum.
Abbreviations: FWHM, full-width, half-maximum; Nav, neutravidin; PBS, 
phosphate-buffered saline; QD, quantum dots; SNP, silica nanoparticles. International Journal of Nanomedicine 2007:2(2) 232
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nuclear stain DAPI. QD-SNP-Nav-αCD3 ﬂ  uorescence did 
not overlap that of DAPI suggesting that, after endocytosis, 
QD-SNP-Nav-αCD3 was not transported to the nucleus. 
Furthermore, staining using rabbit anti-CD107A followed 
by Texas Red-labeled goat anti-rabbit antibody to visualize 
the lysosomes, the organelles that digest macromolecules, 
showed that the red (lysosome) and green (QD-SNP-Nav-
αCD3) ﬂ  uorescence overlapped indicating that after cellular 
uptake some endocytotic vesicles containing QD-SNP-Nav-
αCD3 fused with lysosomes (Figure 5B). 
Jurkat cells that had been treated with QD-SNP-Nav-
αCD3 at 4 °C or those treated with QD-SNP-Nav alone, 
or those previously incubated with unconjugated αCD3, 
either at 4 °C or 37 °C, exhibited weak internal ﬂ  uorescence 
(Figure 5C). Moreover, only a few adherent HeLa cells, 
which lack CD3 receptor, incubated with QD-SNP-Nav-
αCD3 showed extremely weak internal red ﬂ  uorescence.
Overall, these results suggest that without stimulation of 
the Jurkat CD3 membrane receptor (by QD-SNP-Nav alone 
or in presence of nonconjugated αCD3) or treatment of 
HeLa cells with QD-SNP-Nav-αCD3 in absence of the CD3 
surface receptor the endocytotic uptake of the nanoassembly 
was weak and most likely due to nonspeciﬁ  c interactions 
between the nanoassembly and hydrophobic regions of the 
cell surface. On the other hand, the endocytotic uptake of 
the QD-SNP-Nav was strongly ampliﬁ  ed by speciﬁ  c CD3 
receptor-mediated endocytosis with αCD3 crosslinking of 
the CD3 surface receptor to the nanoassembly through biotin-
neutravidin binding. Furthermore, once internalized, some 
of the nanoassembly colocalized with lysosomes. 
Figure 4 Absorbance (A) and normalized emission (B) spectra of QD in toluene (dotted line) and QD-SNP-Nav dispersed in PBS (solid line).  
Abbreviations: Nav, neutravidin; PBS, phosphate-buffered saline; QD, quantum dots; silica nanoparticles.
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Figure 3 Optical (A) and confocal (B) ﬂ  uorescent images of QD-SNP-Nav dispersed in PBS. That both ﬁ  elds displayed uniform ﬂ  uorescence suggests that the nanoassem-
blies were fully dispersed in PBS (scale bars approximately 10 μm).
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Conclusions 
We prepared QD-doped silica nanoparticles coated with neu-
travidin (QD-SNP-Nav), which were visible by conventional 
ﬂ  uorescent microscopy. These nanoassemblies which are 
able to exploit the strong afﬁ  nity between a functionalized 
biotin and neutravidin, and have the potential for further 
functionalization with macromolecules, nucleic acids, and 
polymers. This ﬂ  uorescent nanoassembly was delivered into 
Jurkat T cells through CD3 receptor-mediated endocytosis 
and was partially released to lysosomes. In this regard, 
QD-SNP-Nav represents a potentially useful scaffold for 
constructing speciﬁ  c intracellular nanoprobes. 
In the future we plan to investigate whether QD-SNP-Nav 
functionalized with a synthetic pH-sensitive polymer can 
release drug to the cytoplasm compartment or can deliver 
nucleic acids into a cell. 
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